Literature DB >> 10592326

Attenuation of bleomycin-induced Hprt mutant frequency in female and male rats by calorie restriction.

A Aidoo1, V G Desai, L E Lyn-Cook, J J Chen, R J Feuers, D A Casciano.   

Abstract

Calorie restriction modulates spontaneous and chemically induced tumors and increases maximal life span in experimental animals; however, the mechanism by which calorie restriction exerts its ameliorating effects is not fully elucidated, although reduced levels of reactive oxygen species (ROS) by calorie restriction has generated much interest. In the present study, we have determined whether or not calorie restriction would affect the mutagenic response in rats treated with bleomycin (BLM) a radiomimetic drug that is associated with DNA damage by a free radical mechanism. Fourteen weeks after weaning, the rats were divided into two groups; ad libitum (AL)-fed and 40% calorie restriction. Both AL and calorie-restricted animals were injected with 2.5, 5.0 and 10.0 mg BLM/kg, or with phosphate-buffered saline (PBS), and they were killed 4 weeks post drug treatment. Lymphocytes from the spleens were seeded in 96-well microtiter plates to determine mutant frequency in the hypoxantine guanine phosphoribosyl transferase (Hprt) gene. The mutant frequency in the BLM-treated rats was higher in AL males (P=0.001), and AL females (P=0.0174) than in their calorie-restricted counterparts. The difference in mutagenic response relative to AL males and AL females appeared unrelated to a low percent cloning efficiency seen in the males, since the mean absolute number of Hprt mutant clones was higher in the AL males compared to the females. A reduction in animal weight by calorie restriction was significant in both sexes (P<0.001), but the dose effect appeared non-significant. The results indicate that calorie intake of 60% reduced the mutagenic response of BLM, a compound known to induce oxidative DNA damage, and suggest a possible decrease in ROS as a function of calorie restriction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10592326     DOI: 10.1016/s0027-5107(99)00197-9

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  6 in total

1.  Stress resistance and aging: influence of genes and nutrition.

Authors:  James M Harper; Adam B Salmon; Yayi Chang; Michael Bonkowski; Andrzej Bartke; Richard A Miller
Journal:  Mech Ageing Dev       Date:  2006-05-19       Impact factor: 5.432

2.  Fasting protects against the side effects of irinotecan treatment but does not affect anti-tumour activity in mice.

Authors:  Sander A Huisman; Peter de Bruijn; Inge M Ghobadi Moghaddam-Helmantel; Jan N M IJzermans; Erik A C Wiemer; Ron H J Mathijssen; Ron W F de Bruin
Journal:  Br J Pharmacol       Date:  2016-02-08       Impact factor: 8.739

3.  Fasting protects against the side effects of irinotecan but preserves its anti-tumor effect in Apc15lox mutant mice.

Authors:  Sander A Huisman; Wendy Bijman-Lagcher; Jan N M IJzermans; Ron Smits; Ron W F de Bruin
Journal:  Cell Cycle       Date:  2015-05-08       Impact factor: 4.534

4.  The MDT-15 subunit of mediator interacts with dietary restriction to modulate longevity and fluoranthene toxicity in Caenorhabditis elegans.

Authors:  Jennifer Schleit; Valerie Z Wall; Marissa Simko; Matt Kaeberlein
Journal:  PLoS One       Date:  2011-11-21       Impact factor: 3.240

5.  KLF-1 orchestrates a xenobiotic detoxification program essential for longevity of mitochondrial mutants.

Authors:  Marija Herholz; Estela Cepeda; Linda Baumann; Alexandra Kukat; Johannes Hermeling; Sarah Maciej; Karolina Szczepanowska; Victor Pavlenko; Peter Frommolt; Aleksandra Trifunovic
Journal:  Nat Commun       Date:  2019-07-25       Impact factor: 14.919

6.  The effects of short-term calorie restriction on mutations in the spleen cells of infant-irradiated mice.

Authors:  Saori Kakomi; Takafumi Nakayama; Yi Shang; Chizuru Tsuruoka; Masaaki Sunaoshi; Takamitsu Morioka; Yoshiya Shimada; Shizuko Kakinuma; Akira Tachibana
Journal:  J Radiat Res       Date:  2020-03-23       Impact factor: 2.724

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.